Is TransMedics Group, Inc. overvalued?

TransMedics Group, Inc. (TMDX) — key valuation metrics and fundamentals.

No verdict

Price

$88.25

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$3.05B

Dividend yield

0.0%

Return on equity

33.0%

Sector

Healthcare

Fair value compares TMDX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks